Mitotane (o,p'-DDD).
D000302:Adrenal Cortex / Q000187:drug effects / Q000378:metabolism; D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy* / Q000601:surgery; D000818:Animals; D002277:Carcinoma / Q000188:drug therapy* / Q000601:surgery; D004285:Dogs; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007275:Injections, Intravenous; D008939:Mitotane / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D009362:Neoplasm Metastasis; D009468:Neuromuscular Diseases / Q000139:chemically induced; D051381:Rats; D012871:Skin Diseases / Q000139:chemically induced; D013997:Time Factors; D014018:Tissue Distribution
D008939:Mitotane